Harbour Investments »

Cadrenal Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 100 13.83
2025-06-30 $1.2k 100 12.05

More positions owned by Harbour Investments

Vanguard Index Fds &p 500 Etf Shs (VOO)
Invesco Qqq Tr Nit Ser 1 (QQQ)
First Tr Exchange-traded Mid Risng Etf (SDVY)
First Tr Exchng Traded Fd Vi T Vest Laddered (BUFR)
Ishares Tr Ore S&p Mcp Etf (IJH)
First Tr Exchng Traded Fd Vi Mith Unconstrai (UCON)
Apple Om (AAPL)
Ishares Tr Ore S&p500 Etf (IVV)
First Tr Exchange-traded Ap Strength Etf (FTCS)
Schwab Strategic Tr S Lrg Cap Etf (SCHX)
Spdr S&p 500 Etf Tr R Unit (SPY)
Spdr Series Trust Ortfolio S&p500 (SPLG)
Schwab Strategic Tr S Dividend Eq (SCHD)
Nvidia Corporation Om (NVDA)
Capital Grp Fixed Incm Etf T Ore Plus Incm (CGCP)

View all positions for Harbour Investments

Top funds holding Cadrenal Therapeutics

Vanguard Group
Citadel Advisors
LPL Financial
Geode Capital Management
Jpmorgan Chase & Co
BlackRock
UBS Group
Advisor Group Holdings
Rockefeller Capital Management
Jones Financial Companies, L.L
Hartland & Co
Harbour Investments
Wells Fargo & Company
Archer Investment Corp
IFP Advisors

View all funds holding Cadrenal Therapeutics